Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec;7(6):497-502.
doi: 10.5114/jcb.2015.56465. Epub 2015 Dec 16.

Brachytherapy in non melanoma skin cancer of eyelid: a systematic review

Rezarta Frakulli  1 , Andrea Galuppi  1 , Silvia Cammelli  1 , Gabriella Macchia  2 , Simona Cima  3 , Maria A Gambacorta  4 , Ines Cafaro  5 , Luca Tagliaferri  4 , Elisabetta Perrucci  6 , Milly Buwenge  1 , Giovanni Frezza  7 , Vincenzo Valentini  4 , Alessio G Morganti  1
Affiliations
Review

Brachytherapy in non melanoma skin cancer of eyelid: a systematic review

Rezarta Frakulli et al. J Contemp Brachytherapy. 2015 Dec.

Abstract

Purpose: Non melanoma skin cancers (NMSC) of eyelid are uncommon. Many treatments approach are available with surgery being considered as the gold standard. Radiotherapy is an effective alternative in patients unfit for surgery. Brachytherapy (BT) might be a better therapeutic option due high radiation dose concentration to the tumor and rapid dose fall-off resulting in normal tissues sparing. The aim of this review is to evaluate local control, toxicity, and functional cosmetic outcome of BT in NMSC of eyelid.

Material and methods: A systematic search of the bibliographic databases PubMed, Scopus, and Cochrane Library from the earliest possible date through October 2015 was performed. Only studies published in English were included.

Results: Six articles fulfilled the selection criteria and were included in our review. Due to high risk of bias, all studies were classified to provide a low level of evidence (according to Scottish Intercollegiate Guidelines Network Classification). No randomized controlled trials or case control studies were founded. Brachytherapy was well tolerated with acceptable toxicity and high local control rates (median: 95.2%). Functional and cosmetic outcome were reported in five study as acceptable good functional-cosmetic outcome (median: 100%).

Conclusions: To date, few evidences are available on the role of BT in eyelid NMSC, and they show satisfactory results in terms of local control and functional cosmetic outcome. Therefore, prospective controlled trials are justified.

Keywords: brachytherapy; eyelid; non melanoma skin cancer; systematic review.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow chart of systematic search and review process
See this image and copyright information in PMC

References

    1. Petsuksiri J, Frank SJ, Garden AS, et al. Outcomes after radiotherapy for squamous cell carcinoma of the eyelid. Cancer. 2008;112:111–118. - PubMed
    1. Cook BE, Jr, Bartley GB. Treatment options and future prospects for the management of 166 eyelid malignancies: an evidence-based update. Ophthalmology. 2001;108:2088–2098. - PubMed
    1. Vu A, Laub D., Jr. Metastatic Basal cell carcinoma: a case report and review of the literature. Eplasty. 2011;11:1–7. - PMC - PubMed
    1. Rowe DE, Carroll RJ, Day CL., Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26:976–990. - PubMed
    1. Murchinson AP, Walrath JD, Washington CV. Non-surgical treatments of primary, non-melanoma eyelid malignancies: a review. Clin Experiment Ophthalmol. 2011;39:65–83. - PubMed

LinkOut - more resources